Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Cell- and Tissue-Based Therapy × Clear all

Phase

Status

Sponsor Class

OTHER 14 INDUSTRY 2 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1 Erectile Dysfunction 1

Interventions

Cisplatin 40 Capecitabine 35 Radiotherapy 30 Drug Therapy 29 Paclitaxel 28 Gemcitabine 28 Carboplatin 27 apatinib 26 Cyclophosphamide 26 Oxaliplatin 25 Docetaxel 25 Irinotecan 24 tislelizumab 23 Fluorouracil 21 Bevacizumab 21 Surgical Procedures, Operative 18 Nivolumab 18 pembrolizumab 17 Exercise 15 fludarabine 14 camrelizumab 14 Radiation 14 Metformin 14 Blood Specimen Collection 14 S 1 (combination) 13 Control Groups 12 Standard of Care 10 Pemetrexed 10 Immune Checkpoint Inhibitors 10 Vinorelbine 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01089387 2025-12-04

INSTIN

Institut National de la Santé Et de la Recherche Médicale, France

Phase 1/2 Completed

Erectile Dysfunction, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡